Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier
WebMD

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine
WebMD

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion
    WebMD

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community
    WebMD

    Community

    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

COPD Health Center

Font Size
A
A
A

Breo Ellipta Approved for COPD

Respiratory disease is the third-leading cause of death in U.S.

WebMD News from HealthDay

By Scott Roberts

HealthDay Reporter

FRIDAY, May 10 (HealthDay News) -- Americans with chronic obstructive pulmonary disease (COPD) may have new help in their quest to breathe better, with the approval of Breo Ellipta on Friday.

This combination drug has been approved by the Food and Drug Administration to treat COPD, which includes chronic bronchitis or emphysema.

COPD is the third-leading cause of death in the U.S. behind heart disease and cancer, with typical symptoms including chronic cough, chest tightness and excess phlegm. Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) is designed to reduce lung inflammation and to relax muscles that impact the lung airways, the FDA said Friday in a news release.

The drug's safety and effectiveness were clinically evaluated in some 7,700 people with COPD. Common side effects included nasal inflammation, upper respiratory infection and headache.

Less common but more serious side effects could include bone fracture and pneumonia, the agency said.

The drug's label will carry a warning of increased risk for asthma-related death. The medication has not been tested in, or approved for, people with asthma, the FDA warned.

Breo Ellipta was developed by North Carolina-based GlaxoSmithKline and San Francisco-based Theravance.

Today on WebMD

man talking to his doctor
Check your COPD risk.
woman using inhaler
What is the top cause of this condition?
 
chest x-ray
7 early warning signs.
Senior couple stretching
10 exercises for people With COPD.
 
Bronchitis Overview
Article
Senior woman blowing dandelion
ARTICLE
 
Living With Copd
VIDEO
human lung graphic
Article
 
Energy Boosting Foods
Slideshow
red heart and ekg
Article
 
Living With Copd
Article
Senior couple stretching
Slideshow